Cabaletta Bio Inc. (CABA)
1.78
-0.02 (-1.39%)
At close: Mar 03, 2025, 12:44 PM
Cabaletta Bio Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.43M | 3.68M | 733K | 354K | 104K | n/a | n/a |
| Gross Profit | -1.43M | -3.68M | -733K | -354K | -104K | n/a | n/a |
| Operating Income | -74.66M | -54.14M | -46.31M | -33.83M | -18.68M | -6.19M | -250K |
| Interest Income | 6.99M | 1.16M | 24K | 494K | 1.74M | 235K | n/a |
| Pretax Income | -67.67M | -52.98M | -46.29M | -33.34M | -16.94M | -12.2M | -250K |
| Net Income | -67.67M | -51.81M | -45.53M | -32.49M | -15.1M | -12.2M | -250K |
| Selling & General & Admin | 19.24M | 14.84M | 13.82M | 12.46M | 7.01M | 1.73M | 250K |
| Research & Development | 55.42M | 39.3M | 32.49M | 21.38M | 11.67M | 4.47M | n/a |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | -6.24M | n/a |
| Operating Expenses | 74.66M | 54.14M | 46.31M | 33.83M | 18.68M | 6.19M | 250K |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -83.33K |
| Cost & Expenses | 74.66M | 54.14M | 46.31M | 33.83M | 18.68M | 6.19M | 250K |
| Income Tax | n/a | -1.16M | -757K | -848K | -1.84M | -235K | -333.33K |
| Shares Outstanding (Basic) | 40.95M | 29.34M | 25.74M | 23.15M | 24.03M | 14.51M | 24.03M |
| Shares Outstanding (Diluted) | 40.95M | 29.34M | 25.74M | 23.15M | 24.03M | 14.51M | 24.03M |
| EPS (Basic) | -1.65 | -1.77 | -1.77 | -1.4 | -0.63 | -0.84 | -0.01 |
| EPS (Diluted) | -1.65 | -1.77 | -1.77 | -1.4 | -0.63 | -0.84 | -0.01 |
| EBITDA | -73.23M | -52.96M | -45.58M | -33.48M | -18.68M | -6.01M | 83.33K |
| Depreciation & Amortization | 1.43M | 3.68M | 733K | 354K | 104K | 6.19M | 333.33K |